Cell Isolation / Cell Separation Market worth 6.3 Billion USD by 2020

The report "Cell Isolation/Cell Separation Market by Product (Reagent, Media, Serum, Bead, Centrifuge), Cell Type (Human, Stem Cell, Animal), Technique (Filtration, Surface Marker), Application (Research, IVD) & End user (Hospital, Biotechnology) - Forecast to 2020", provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the cell isolation market along with the estimates and forecasts of the revenue and share analysis.

Browse 254 market tables and 42 figures spread through 246 pages and in-depth TOC on "Cell Isolation/Cell Separation Market by Product (Reagent, Media, Serum, Bead, Centrifuge), Cell Type (Human, Stem Cell, Animal), Technique (Filtration, Surface Marker), Application (Research, IVD) & End user (Hospital, Biotechnology) - Forecast to 2020"
http://www.marketsandmarkets.com/Market-Reports/cell-isolation-market-103931479.html
Early buyers will receive 10% customization on reports.

The global cell isolation market is expected to reach USD 6.3 Billion by 2020 from USD 2.9 Billion in 2015, growing at a CAGR of 16.8% from 2015 to 2020.

The report segments this market on the basis of product, cell type, technique, application, and end user. Among various techniques, the centrifugation-based cell isolation technique is expected to account for the largest share in 2015, while surface marker-based cell isolation technique is expected to account for the fastest-growing segment in the cell isolation market, owing to technological advancement due to which new products are being launched in the market. Furthermore, rising usage of surface marker-based cell isolation techniques in stem cell and cancer research is another major reason for the growth of this market.

Based on geography, the global cell isolation market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is expected to account for the largest share of the market by the end of 2015. Growth in this regional segment is driven by various factors such as increasing government support for cancer and stem cell research and expanding biotechnology and biopharmaceutical industries in this region.

End users, included in the cell isolation market are research laboratories and institutes, hospitals and diagnostic laboratories, cell banks, and biotechnology and biopharmaceutical industries. The research laboratories and institutes segment is expected to account for the largest share of the global cell isolation market in 2015. The large share of this segment can be attributed to the wide usage of cell isolation products for cancer and stem cell research.

Prominent players in the cell isolation market are BD Biosciences (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.K.), Merck Millipore (U.S.), Miltenyi Biotec (Germany), pluriSelect (U.S.), STEMCELL Technologies (Canada), Sigma-Aldrich Corporation (U.S.), Terumo BCT (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).